Literature DB >> 10065898

In vivo antithrombotic effects of a nitric oxide-releasing aspirin derivative, NCX-4016.

J L Wallace1, M N Muscara, W McKnight, M Dicay, P Del Soldato, G Cirino.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10065898     DOI： 10.1016/s0049-3848(98)00134-0

Source DB:  PubMed          Journal:  Thromb Res        ISSN： 0049-3848            Impact factor:   3.944


× No keyword cloud information.
  14 in total

1.  Platelets modulate gastric ulcer healing: role of endostatin and vascular endothelial growth factor release.

Authors:  L Ma; S N Elliott; G Cirino; A Buret; L J Ignarro; J L Wallace
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-15       Impact factor: 11.205

Review 2.  Recent developments in nitric oxide donor drugs.

Authors:  M R Miller; I L Megson
Journal:  Br J Pharmacol       Date:  2007-04-02       Impact factor: 8.739

3.  Efficacy and age-related effects of nitric oxide-releasing aspirin on experimental restenosis.

Authors:  Claudio Napoli; Giancarlo Aldini; John L Wallace; Filomena de Nigris; Roberto Maffei; Pasquale Abete; Domenico Bonaduce; Gianluigi Condorelli; Franco Rengo; Vincenzo Sica; Francesco P D'Armiento; Chiara Mignogna; Gaetano de Rosa; Mario Condorelli; Lilach O Lerman; Louis J Ignarro
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-29       Impact factor: 11.205

4.  Inhibition of cyclo-oxygenase-2 exacerbates ischaemia-induced acute myocardial dysfunction in the rabbit.

Authors:  Giuseppe Rossoni; Marcelo N Muscara; Giuseppe Cirino; John L Wallace
Journal:  Br J Pharmacol       Date:  2002-03       Impact factor: 8.739

5.  Influence of hydrocortisone, prednisolone, and NO association on the evolution of acute pancreatitis.

Authors:  Laura Iris Cosen-Binker; Marcelo Gustavo Binker; Rodica Cosen; Gustavo Negri; Osvaldo Tiscornia
Journal:  Dig Dis Sci       Date:  2006-05-03       Impact factor: 3.199

Review 6.  Antiplatelet therapies for the treatment of cardiovascular disease.

Authors:  Alan D Michelson
Journal:  Nat Rev Drug Discov       Date:  2010-02       Impact factor: 84.694

7.  Effects of nitric oxide-releasing aspirin versus aspirin on restenosis in hypercholesterolemic mice.

Authors:  C Napoli; G Cirino; P Del Soldato; R Sorrentino; V Sica; M Condorelli; A Pinto; L J Ignarro
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-27       Impact factor: 11.205

Review 8.  Pharmacology and potential therapeutic applications of nitric oxide-releasing non-steroidal anti-inflammatory and related nitric oxide-donating drugs.

Authors:  J E Keeble; P K Moore
Journal:  Br J Pharmacol       Date:  2002-10       Impact factor: 8.739

9.  NCX4016 (NO-Aspirin) has multiple inhibitory effects in LPS-stimulated human monocytes.

Authors:  P Minuz; M Degan; S Gaino; A Meneguzzi; V Zuliani; C L Santonastaso; P D Soldato; A Lechi
Journal:  Br J Pharmacol       Date:  2001-10       Impact factor: 8.739

10.  NCX 4016, a nitric oxide-releasing aspirin, modulates adrenergic vasoconstriction in the perfused rat tail artery.

Authors:  Giuseppe Rossoni; Barbara Manfredi; Piero Del Soldato; Ferruccio Berti
Journal:  Br J Pharmacol       Date:  2002-09       Impact factor: 8.739
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.